Summer 1970

The U.S. Nitrogen Industry by George C. Sweeney, Jr. (page 3) Learn the Oil Alphabet by Melvin E. Long (7) Weed Control with Repeated Applications of Tordon Herbicides by John W. Gibson (9) Plants Speed Formation of Soil by Brij L. Sawney (12) St. Augustine Decline (SAD) A Virus Disease of St. Augustine Grass by Norman L. McCoy, Robert W. Toler, and Jose Amador (15) The Problem of Responsibility for Recreation by Ronald F. Paige (19) Editorial (20) Massachusetts Fine Turf Conference (23) Dickinson Memorial Fund (23

Barriers and facilitators of effective self-management in asthma: systematic review and thematic synthesis of patient and healthcare professional views

Self-management is an established, effective approach to controlling asthma, recommended in guidelines. However, promotion, uptake and use among patients and health-care professionals remain low. Many barriers and facilitators to effective self-management have 25 been reported, and views and beliefs of patients and health care professionals have been explored in qualitative studies. We conducted a systematic review and thematic synthesis of qualitative research into self-management in patients, carers and health care professionals regarding self-management of asthma, to identify perceived barriers and facilitators associated with reduced effectiveness of asthma self-management interventions. Electronic databases and guidelines were searched systematically for qualitative literature that explored factors relevant to facilitators and barriers to uptake, adherence, or outcomes of self-management in patients with asthma. Thematic synthesis of the 56 included studies identified 11 themes: 1) partnership between patient and health care professional; 2) issues around medication; 3) education about asthma and its management; 4) health beliefs; 5) self-management interventions; 6) co-morbidities 7) mood disorders and anxiety; 8) social support; 9) non-pharmacological methods; 10) access to healthcare; 11) professional factors. From this, perceived barriers and facilitators were identified at the level of individuals with asthma (and carers), and health-care professionals. Future work addressing the concerns and beliefs of adults, adolescents and children (and carers) with asthma, effective communication and partnership, tailored support and education (including for ethnic minorities and at risk groups), and telehealthcare may improve how self-management is recommended by professionals and used by patients. Ultimately, this may achieve better outcomes for people with asthma

Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries

Background Global inequalities in access to health care are reflected in differences in cancer survival. The CONCORD programme was designed to assess worldwide differences and trends in population-based cancer survival. In this population-based study, we aimed to estimate survival inequalities globally for several subtypes of childhood leukaemia. Methods Cancer registries participating in CONCORD were asked to submit tumour registrations for all children aged 0-14 years who were diagnosed with leukaemia between Jan 1, 1995, and Dec 31, 2009, and followed up until Dec 31, 2009. Haematological malignancies were defined by morphology codes in the International Classification of Diseases for Oncology, third revision. We excluded data from registries from which the data were judged to be less reliable, or included only lymphomas, and data from countries in which data for fewer than ten children were available for analysis. We also excluded records because of a missing date of birth, diagnosis, or last known vital status. We estimated 5-year net survival (ie, the probability of surviving at least 5 years after diagnosis, after controlling for deaths from other causes [background mortality]) for children by calendar period of diagnosis (1995-99, 2000-04, and 2005-09), sex, and age at diagnosis (< 1, 1-4, 5-9, and 10-14 years, inclusive) using appropriate life tables. We estimated age-standardised net survival for international comparison of survival trends for precursor-cell acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML). Findings We analysed data from 89 828 children from 198 registries in 53 countries. During 1995-99, 5-year agestandardised net survival for all lymphoid leukaemias combined ranged from 10.6% (95% CI 3.1-18.2) in the Chinese registries to 86.8% (81.6-92.0) in Austria. International differences in 5-year survival for childhood leukaemia were still large as recently as 2005-09, when age-standardised survival for lymphoid leukaemias ranged from 52.4% (95% CI 42.8-61.9) in Cali, Colombia, to 91.6% (89.5-93.6) in the German registries, and for AML ranged from 33.3% (18.9-47.7) in Bulgaria to 78.2% (72.0-84.3) in German registries. Survival from precursor-cell ALL was very close to that of all lymphoid leukaemias combined, with similar variation. In most countries, survival from AML improved more than survival from ALL between 2000-04 and 2005-09. Survival for each type of leukaemia varied markedly with age: survival was highest for children aged 1-4 and 5-9 years, and lowest for infants (younger than 1 year). There was no systematic difference in survival between boys and girls. Interpretation Global inequalities in survival from childhood leukaemia have narrowed with time but remain very wide for both ALL and AML. These results provide useful information for health policy makers on the effectiveness of health-care systems and for cancer policy makers to reduce inequalities in childhood survival

Erratum to: 36th International Symposium on Intensive Care and Emergency Medicine

[This corrects the article DOI: 10.1186/s13054-016-1208-6.]

25th annual computational neuroscience meeting: CNS-2016

The same neuron may play different functional roles in the neural circuits to which it belongs. For example, neurons in the Tritonia pedal ganglia may participate in variable phases of the swim motor rhythms [1]. While such neuronal functional variability is likely to play a major role the delivery of the functionality of neural systems, it is difficult to study it in most nervous systems. We work on the pyloric rhythm network of the crustacean stomatogastric ganglion (STG) [2]. Typically network models of the STG treat neurons of the same functional type as a single model neuron (e.g. PD neurons), assuming the same conductance parameters for these neurons and implying their synchronous firing [3, 4]. However, simultaneous recording of PD neurons shows differences between the timings of spikes of these neurons. This may indicate functional variability of these neurons. Here we modelled separately the two PD neurons of the STG in a multi-neuron model of the pyloric network. Our neuron models comply with known correlations between conductance parameters of ionic currents. Our results reproduce the experimental finding of increasing spike time distance between spikes originating from the two model PD neurons during their synchronised burst phase. The PD neuron with the larger calcium conductance generates its spikes before the other PD neuron. Larger potassium conductance values in the follower neuron imply longer delays between spikes, see Fig. 17.Neuromodulators change the conductance parameters of neurons and maintain the ratios of these parameters [5]. Our results show that such changes may shift the individual contribution of two PD neurons to the PD-phase of the pyloric rhythm altering their functionality within this rhythm. Our work paves the way towards an accessible experimental and computational framework for the analysis of the mechanisms and impact of functional variability of neurons within the neural circuits to which they belong

Krotite, CaAl_2O_4, a new refractory mineral from the NWA 1934 meteorite

Krotite, CaAl_2O_4, occurs as the dominant phase in an unusual Ca-,Al-rich refractory inclusion from the NWA 1934 CV3 carbonaceous chondrite. Krotite occupies the central and mantle portions of the inclusion along with minor perovskite, gehlenite, hercynite, and Cl-bearing mayenite, and trace hexamolybdenum. A layered rim surrounds the krotite-bearing regions, consisting from inside to outside of grossite, mixed hibonite, and spinel, then gehlenite with an outermost layer composed of Al-rich diopside. Krotite was identified by XRD, SEM-EBSD, micro-Raman, and electron microprobe. The mean chemical composition determined by electron microprobe analysis of krotite is (wt%) Al_2O_3 63.50, CaO 35.73, sum 99.23, with an empirical formula calculated on the basis of 4 O atoms of Ca_(1.02)Al_(1.99)O_4. Single-crystal XRD reveals that krotite is monoclinic, P2_1/n; a = 8.6996(3), b = 8.0994(3), c = 15.217(1) Å, β = 90.188(6), and Z = 12. It has a stuffed tridymite structure, which was refined from single-crystal data to R_1 = 0.0161 for 1014 F_o > 4σF reflections. Krotite is colorless and transparent with a vitreous luster and white streak. Mohs hardness is ~6½. The mineral is brittle, with a conchoidal fracture. The calculated density is 2.94 g/cm3. Krotite is biaxial (–), α = 1.608(2), β = 1.629(2), γ = 1.635(2) (white light), 2V_(meas) = 54.4(5)°, and 2V_(calc) = 55.6°. No dispersion was observed. The optical orientation is X = b; Y ≈ a; Z ≈ c. Pleochroism is colorless to very pale gray, X > Y = Z. Krotite is a low-pressure CaAl_2O_4 mineral, likely formed by condensation or crystallization from a melt in the solar nebula. This is the first reported occurrence of krotite in nature and it is one of the earliest minerals formed in the solar system

Brearleyite, Ca_(12)Al_(14)O_(32)Cl_2, a new alteration mineral from the NWA 1934 meteorite

Brearleyite (IMA 2010-062, Ca_(12)Al_(14)O_(32)Cl_2) is a Cl-bearing mayenite, occurring as fine-grained aggregates coexisting with hercynite, gehlenite, and perovskite in a rare krotite (CaAl_2O_4) dominant refractory inclusion from the Northwest Africa 1934 CV3 carbonaceous chondrite. The phase was characterized by SEM, TEM-SAED, micro-Raman, and EPMA. The mean chemical composition of the brearleyite is (wt%) Al_2O_3 48.48, CaO 45.73, Cl 5.12, FeO 0.80, Na_2O 0.12, TiO_2 0.03, –O 1.16, sum 99.12. The corresponding empirical formula calculated on the basis of 34 O+Cl atoms is (Ca_(11.91)Na_(0.06))Σ_(11.97)Al_(13.89)Fe_(0.16)Ti_(0.01))Σ_(14.06)O_(31.89)Cl_(2.11). The Raman spectrum of brealryeite indicates very close structural similarity to synthetic Ca_(12)Al_(14)O_(32)Cl_2. Rietveld refinement of an integrated TEM-SAED ring pattern from a FIB section quantifies this structural relationship and indicates that brearleyite is cubic, ⌈43d; a = 11.98(8) Å, V = 1719.1(2) Å3, and Z = 2. It has a framework structure in which AlO4 tetrahedra share corners to form eight-membered rings. Within this framework, the Cl atom is located at a special position (3/8,0,1/4) with 0.4(2) occupancy and Ca appears to be disordered on two partially occupied sites similar to synthetic Cl-mayenite. Brearleyite has a light olive color under diffuse reflected light and a calculated density of 2.797 g/cm3. Brearleyite is not only a new meteoritic Ca-,Al-phase, but also a new meteoritic Cl-rich phase. It likely formed by the reaction of krotite with Cl-bearing hot gases or fluids

Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

Background: Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillance of cancer survival by central analysis of population-based registry data, as a metric of the effectiveness of health systems, and to inform global policy on cancer control. Methods: Individual tumour records were submitted by 279 population-based cancer registries in 67 countries for 25·7 million adults (age 15–99 years) and 75 000 children (age 0–14 years) diagnosed with cancer during 1995–2009 and followed up to Dec 31, 2009, or later. We looked at cancers of the stomach, colon, rectum, liver, lung, breast (women), cervix, ovary, and prostate in adults, and adult and childhood leukaemia. Standardised quality control procedures were applied; errors were corrected by the registry concerned. We estimated 5-year net survival, adjusted for background mortality in every country or region by age (single year), sex, and calendar year, and by race or ethnic origin in some countries. Estimates were age-standardised with the International Cancer Survival Standard weights. Findings: 5-year survival from colon, rectal, and breast cancers has increased steadily in most developed countries. For patients diagnosed during 2005–09, survival for colon and rectal cancer reached 60% or more in 22 countries around the world; for breast cancer, 5-year survival rose to 85% or higher in 17 countries worldwide. Liver and lung cancer remain lethal in all nations: for both cancers, 5-year survival is below 20% everywhere in Europe, in the range 15–19% in North America, and as low as 7–9% in Mongolia and Thailand. Striking rises in 5-year survival from prostate cancer have occurred in many countries: survival rose by 10–20% between 1995–99 and 2005–09 in 22 countries in South America, Asia, and Europe, but survival still varies widely around the world, from less than 60% in Bulgaria and Thailand to 95% or more in Brazil, Puerto Rico, and the USA. For cervical cancer, national estimates of 5-year survival range from less than 50% to more than 70%; regional variations are much wider, and improvements between 1995–99 and 2005–09 have generally been slight. For women diagnosed with ovarian cancer in 2005–09, 5-year survival was 40% or higher only in Ecuador, the USA, and 17 countries in Asia and Europe. 5-year survival for stomach cancer in 2005–09 was high (54–58%) in Japan and South Korea, compared with less than 40% in other countries. By contrast, 5-year survival from adult leukaemia in Japan and South Korea (18–23%) is lower than in most other countries. 5-year survival from childhood acute lymphoblastic leukaemia is less than 60% in several countries, but as high as 90% in Canada and four European countries, which suggests major deficiencies in the management of a largely curable disease. Interpretation: International comparison of survival trends reveals very wide differences that are likely to be attributable to differences in access to early diagnosis and optimum treatment. Continuous worldwide surveillance of cancer survival should become an indispensable source of information for cancer patients and researchers and a stimulus for politicians to improve health policy and health-care systems

Dentists, antibiotics and Clostridium difficile-associated disease

Dentists prescribe significant volumes of antimicrobial drugs within primary care settings. There is good evidence that many of the prescriptions are not justified by current clinical guidance and that that there is considerable misuse of these drugs in dentistry. One of the risks associated with antibiotic administration is Clostridium difficile-associated disease (CDAD), an entity of which many healthcare workers, including dentists, have little knowledge or understanding. This review seeks to identify the extent and nature of the problem and provides an up to date summary of current views on CDAD, with particular reference to community acquired disease. As for all healthcare workers, scrupulous attention to standard infection control procedures and reducing inappropriate antibiotic prescribing are essential to reduce the risks of CDAD, prevent emergence of further resistant strains of microorganisms and maintain the value of the arsenal of antibiotics currently available to us